WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 52
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 62

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 419  418  417  416  414  387  356  320 
Births
Surviving infants
Pop. less than 5 years 19  19  19  19  19  24  29  29 
Pop. less than 15 years 60  62  63  65  66  81  85  77 
Female 15-49 years 95  94  94  94  93  97  93  89 

Number of reported cases

(Click for retrospective incidence data for Malta)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  14 
Mumps
ChartChart
  386 
Pertussis
ChartChart
  106 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Malta)
Vaccine year result method % card seen                                                
BCG          92  93  84  77 
DTP1          98  99*  99*  99*  99*  97 
DTP3          97  99  99  99  96  94  63 
DTP4          98  90 
IPV1          98  99* 
HepB_BD         
HepB3          95  90  94  93  82 
Hib3          97  99  99  99  96  93 
JapEnc         
MCV1          89  98  99  93  84  74  80 
MCV2          91  94  88  91  85 
PCV1         
PCV3         
Pol3          97  99  99  99  96  94  86 
Rota1         
RotaC         
Rubella1          89  98  84  93 
TT2plus          86 
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Malta)
BCG
ChartChart
  77 
DTP1
ChartChart
  98  99  99  99  99  97  84 
DTP3
ChartChart
  97  99  99  99  96  94  63 
HepB3
ChartChart
  95  90  94  93  82 
HepB_BD
ChartChart
 
Hib3
ChartChart
  97  99  99  99  96  93 
MCV1
ChartChart
  89  98  99  93  84  74  80 
MCV2
ChartChart
  91  94  88  91  85 
PCV3
ChartChart
 
Pol3
ChartChart
  97  99  99  99  96  94  86 
RCV1
ChartChart
  89  98  99  93  84  74  80 
RotaC
ChartChart
 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes High risk group parents
DTaPHibIPV 6 weeks; 3, 4, 18 months; Yes
HPV 12 years; +6 months; Yes
HepB_Pediatric 12, 13, 18 months; Yes
Influenza_Adult > 55 years; Yes and health care workers, adults with chronic diseases and pregnant women
Influenza_Pediatric < 5 years; Yes and children with chronic diseases
MMR 13 months; 3 years; Yes
TdIPV 14 years; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number     2012-2015  2011-2013  2010-2012  2010-2014   
Nº of districts with microplans that include activities to raise immunization coverage number     NA     

System performance

Total Nº districts in country number  
Nº districts with DTP3 coverage >=80% number          
% of districts with DTP3 coverage >=80% From 0 to 100%     100  100       
Nº districts with measles (MCV1) coverage >=95% number          
% of districts with MCV1 coverage >=95% From 0 to 100%          

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  NA  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100          100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.